Medicine Man Technologies: Q4 Earnings Insights
Portfolio Pulse from Benzinga Insights
Medicine Man Technologies (OTC:SHWZ) reported Q4 earnings with an EPS of $-0.38, missing estimates by -192.0% against an expected $-0.13. Revenue increased by $3.18 million from the previous year. The company's past earnings performance shows a mixed trend with a notable 8.0% drop in share price following the last quarter's earnings beat.
March 27, 2024 | 8:55 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Medicine Man Technologies reported a significant miss in Q4 earnings with an EPS of -$0.38, far below the estimated -$0.13, although revenue increased by $3.18 million from the previous year.
The significant miss in earnings expectations is likely to negatively impact investor sentiment in the short term, especially considering the company's history of mixed earnings performance and the 8.0% drop in share price following the last quarter's earnings beat. The increase in revenue may provide some buffer, but the large miss in EPS is expected to be the dominant factor affecting the stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100